257 related articles for article (PubMed ID: 23352855)
1. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Radiofrequency Ablation for Hepatic Metastases from Gastrointestinal Stromal Tumor.
Jung JH; Won HJ; Shin YM; Kim PN
J Vasc Interv Radiol; 2015 Dec; 26(12):1797-1802. PubMed ID: 26603498
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
[TBL] [Abstract][Full Text] [Related]
4. Management of liver metastases of gastrointestinal stromal tumors (GIST).
Vassos N; Agaimy A; Hohenberger W; Croner RS
Ann Hepatol; 2015; 14(4):531-9. PubMed ID: 26019040
[TBL] [Abstract][Full Text] [Related]
5. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results.
Bruners P; Schmitz-Rode T; Günther RW; Mahnken A
Rofo; 2008 Mar; 180(3):216-22. PubMed ID: 18278730
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
7. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.
Yoon IS; Shin JH; Han K; Kim PN; Kim KH; Kang YK; Ko HK
Korean J Radiol; 2018; 19(1):54-62. PubMed ID: 29354000
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma.
Kodama H; Yamakado K; Hasegawa T; Takao M; Taguchi O; Fukai I; Sakuma H
J Vasc Interv Radiol; 2014 Mar; 25(3):333-9. PubMed ID: 24581457
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients.
Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
J Vasc Interv Radiol; 2007 Oct; 18(10):1264-9. PubMed ID: 17911517
[TBL] [Abstract][Full Text] [Related]
12. Semiautomated versus manual evaluation of liver metastases treated by radiofrequency ablation.
Keil S; Bruners P; Ohnsorge L; Plumhans C; Behrendt FF; Stanzel S; Sühling M; Günther RW; Das M; Mahnken AH
J Vasc Interv Radiol; 2010 Feb; 21(2):245-51. PubMed ID: 20123208
[TBL] [Abstract][Full Text] [Related]
13. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.
Cheung TT; Chok KS; Chan AC; Yau TC; Chan SC; Poon RT; Fan ST; Lo CM
ANZ J Surg; 2014 Nov; 84(11):827-31. PubMed ID: 23782558
[TBL] [Abstract][Full Text] [Related]
14. Safety and Clinical Outcomes of Percutaneous Radiofrequency Ablation for Intermediate and Large Bone Tumors Using a Multiple-Electrode Switching System: A Phase II Clinical Study.
Nakatsuka A; Yamakado K; Uraki J; Takaki H; Yamanaka T; Fujimori M; Hasegawa T; Sakuma H
J Vasc Interv Radiol; 2016 Mar; 27(3):388-94. PubMed ID: 26723527
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.
Matsui Y; Hiraki T; Gobara H; Fujiwara H; Iguchi T; Shirakawa Y; Fujiwara T; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2014 Oct; 25(10):1566-72. PubMed ID: 25156828
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
Hiraki T; Yamakado K; Ikeda O; Matsuoka T; Kaminou T; Yamagami T; Gobara H; Mimura H; Kawanaka K; Takeda K; Yamashita Y; Inoue Y; Ogawa T; Nishimura T; Kanazawa S
J Vasc Interv Radiol; 2011 Jun; 22(6):741-8. PubMed ID: 21531575
[TBL] [Abstract][Full Text] [Related]
20. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
